[PDF][PDF] Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in …

…, A Buck, R Naumann, K Spaepen… - Journal of clinical …, 2007 - researchgate.net
Spaepen K, Stroobants S, Dupont P, et al: Prognostic value of pretransplantation positron
emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive …

Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F] FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is …

K Spaepen, S Stroobants, P Dupont… - Journal of Clinical …, 2001 - ascopubs.org
PURPOSE: A complete remission (CR) after first-line therapy is associated with longer
progression-free survival (PFS). However, defining CR is not always easy because of the …

[HTML][HTML] Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma

K Spaepen, S Stroobants, P Dupont, P Vandenberghe… - Annals of …, 2002 - Elsevier
Background Less than half of all patients with aggressive non-Hodgkin’s lymphoma (NHL)
are cured with standard chemotherapy. Therefore, it is important to distinguish between …

Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high …

K Spaepen, S Stroobants, P Dupont, P Vandenberghe… - Blood, 2003 - ashpublications.org
The study assessed the prognostic value of fluorine 18-fluorodeoxyglucose positron
emission tomography ([ 18 F]FDG-PET) after salvage chemotherapy before high-dose …

Can positron emission tomography with [18F]‐fluorodeoxyglucose after first‐line treatment distinguish Hodgkin's disease patients who need additional therapy from …

K Spaepen, S Stroobants, P Dupont… - British journal of …, 2001 - Wiley Online Library
To assess the ability of restaging positron emission tomography (PET) scanning to predict
clinical outcome after first‐line treatment in patients with Hodgkin's disease, we included 60 …

[18F]FDG PET monitoring of tumour response to chemotherapy: does [18F]FDG uptake correlate with the viable tumour cell fraction?

K Spaepen, S Stroobants, P Dupont, G Bormans… - European journal of …, 2003 - Springer
Because metabolic changes induced by chemotherapy precede the morphological changes,
fluorine-18 fluorodeoxyglucose positron emission tomography ([ 18 F]FDG PET) is thought …

18FDG PET in oncology: the best and the worst

T Belhocine, K Spaepen, M Dusart… - International …, 2006 - spandidos-publications.com
The clinical added-value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18FDG
PET) in the management of oncology patients is increasingly documented. In the …

Positron emission tomography with [18F]FDG for therapy response monitoring in lymphoma patients

K Spaepen, S Stroobants, G Verhoef… - European journal of …, 2003 - Springer
Lymphomas are a heterogeneous group of diseases with differing histopathology, clinical
behaviour, response to therapy and outcome. Lymphomas are highly sensitive to …

Hodgkin lymphoma: response assessment by revised International Workshop Criteria

…, S Stroobants, W De Wever, K Spaepen… - Leukemia & …, 2007 - Taylor & Francis
Until recently, response assessment in patients with Hodgkin's lymphoma (HL) was primarily
performed by computed tomography (CT). Based on CT, International Workshop Criteria (…

Aggressive and indolent non-Hodgkin's lymphoma: response assessment by integrated international workshop criteria

…, S Stroobants, W De Wever, K Spaepen… - Leukemia & …, 2007 - Taylor & Francis
Until recently, response assessment in patients with lymphoma was primarily performed by
computed tomography (CT). Based on CT, International Workshop Criteria (IWC) were …